Switch to:

Ratios

vs
industry
vs
history
PE Ratio 22.23
IYH's PE Ratio is ranked lower than
100% of the Companies
in the Global industry.

( Industry Median: vs. IYH: 22.23 )
Ranked among companies with meaningful PE Ratio only.
IYH' s PE Ratio Range Over the Past 10 Years
Min: 0  Med: 0 Max: 24.27
Current: 22.23
0
24.27
PE Ratio without NRI 22.23
IYH's PE Ratio without NRI is ranked lower than
100% of the Companies
in the Global industry.

( Industry Median: vs. IYH: 22.23 )
Ranked among companies with meaningful PE Ratio without NRI only.
IYH' s PE Ratio without NRI Range Over the Past 10 Years
Min: 0  Med: 0 Max: 24.27
Current: 22.23
0
24.27
PB Ratio 3.52
IYH's PB Ratio is ranked lower than
100% of the Companies
in the Global industry.

( Industry Median: vs. IYH: 3.52 )
Ranked among companies with meaningful PB Ratio only.
IYH' s PB Ratio Range Over the Past 10 Years
Min: 0  Med: 0 Max: 3.95
Current: 3.52
0
3.95

Dividend & Buy Back

vs
industry
vs
history
Dividend Yield % 2.02
IYH's Dividend Yield % is ranked lower than
100% of the Companies
in the Global industry.

( Industry Median: vs. IYH: 2.02 )
Ranked among companies with meaningful Dividend Yield % only.
IYH' s Dividend Yield % Range Over the Past 10 Years
Min: 0  Med: 0 Max: 2.3
Current: 2.02
0
2.3
5-Year Yield-on-Cost % 2.02
IYH's 5-Year Yield-on-Cost % is ranked lower than
100% of the Companies
in the Global industry.

( Industry Median: vs. IYH: 2.02 )
Ranked among companies with meaningful 5-Year Yield-on-Cost % only.
IYH' s 5-Year Yield-on-Cost % Range Over the Past 10 Years
Min: 0  Med: 0 Max: 2.3
Current: 2.02
0
2.3

More Statistics

Short Percentage of Float0.00%
52-Week Range $136.71 - 157.13
Shares Outstanding (Mil)11,600,000.00
» More Articles for IYH

Headlines

Articles On GuruFocus.com
Some Highlights From Warren Buffett’s Annual Letter 2016 Feb 25 2017 
National Health Investors: 5% Yielding Dividend Achiever With Growth Up Ahead Feb 25 2017 
How General Motors Finished 2016 on a Positive Note Feb 25 2017 
Plan Your Trades and Trade Your Plan Feb 25 2017 
Heineken Releases Annual Report Feb 24 2017 
NIC: Supreme Business, but Large Contract Renewals Warrant Caution Feb 24 2017 
Eldorado Gold Reports 2016 Results Feb 24 2017 
Baron Perspective: Don’t Get Bitten by Biases Feb 24 2017 
Jana Partners Eats Breakfast With Tiffany Feb 24 2017 
HollyFrontier Reports 4th-Quarter 2016 Results Feb 24 2017 

More From Other Websites
Finally, a draft of Obamacare repeal emerges. It would defund Planned Parenthood Feb 24 2017
Eli Lilly & Co.’s Revenues in 4Q16 Feb 23 2017
How to Play Pfizer's Fourth-Quarter Results With ETFs Feb 01 2017
Why GE’s Healthcare Revenues Rose in 4Q16 Jan 27 2017
Analyzing Bristol-Myers Squibb’s Other Segments in 4Q16 Jan 25 2017
How Should Investors Play Healthcare? Jan 24 2017
3 ETFs to Buy If You're Impressed With Johnson & Johnson's Fourth Quarter Jan 24 2017
Why health-care stocks aren’t moving after President Trump’s Obamacare executive order Jan 24 2017
U.S. fund managers betting Trump fails to rewrite Obamacare Jan 24 2017
What’s Expected from Bristol-Myers Squibb’s 4Q16 Earnings? Jan 23 2017
Can Q4 Earnings Revitalize Healthcare ETFs? Jan 23 2017
Will Johnson & Johnson’s Profitability Improve in 4Q16? Jan 23 2017
A Look Into The Economic And Human Cost Of A Partial Obamacare Repeal Jan 12 2017
Gilead Sciences’ Liver Disease Drugs Portfolio Jan 02 2017
What Factors Are Contributing to Gilead Sciences’ Growth? Dec 30 2016
The Competitive Landscape for Enbrel Dec 29 2016
What’s Behind Amgen’s Discounted Valuation? Dec 28 2016
2 Beaten-Down Funds To Buy For 9.4% Dividends, And 3 To Avoid Dec 24 2016
Revenue Drivers for Krystexxa, Horizon’s Orphan Biologic Drug Dec 21 2016
Pfizer Has Strong Track Record since 2010 Dec 15 2016

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK